{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:42:35Z","timestamp":1792590155641,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"vor","delay-in-days":89,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"DOI":"10.1186\/s12887-026-07392-3","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T02:25:23Z","timestamp":1784859923000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Anticoagulation therapy in children with SARS-CoV-2 pneumonia: a retrospective observational study on dosage, efficacy, and safety"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2444-1786","authenticated-orcid":false,"given":"Nguyen The Nguyen","family":"Phung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8809-2699","authenticated-orcid":false,"given":"Thuc Thanh","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nghia","family":"Van Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dung Hoang","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8762-0082","authenticated-orcid":false,"given":"Mai Anh Thi","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"key":"7392_CR1","doi-asserted-by":"publisher","first-page":"997635","DOI":"10.3389\/fpubh.2023.997635","volume":"11","author":"LP Doan","year":"2023","unstructured":"Doan LP, Le Vu MN, Vu GT, et al. The COVID-19 endemic in Vietnam: contextual considerations and implications. Front Public Health. 2023;11:997635.","journal-title":"Front Public Health"},{"key":"7392_CR2","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.jiac.2022.06.010","volume":"28","author":"PNT Nguyen","year":"2022","unstructured":"Nguyen PNT, Thuc TT, Hung NT, et al. Risk factors for disease severity and mortality of children with Covid-19: a study at a Vietnamese Children\u2019s hospital. J Infect Chemother. 2022;28:1380\u20136.","journal-title":"J Infect Chemother"},{"key":"7392_CR3","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00431-025-06051-6","volume":"184","author":"PNT Nguyen","year":"2025","unstructured":"Nguyen PNT, Thuc TT, Hung NT, et al. Coronary artery dilation in children with MIS-C: prevalence, risk factors, and progression. Eur J Pediatr. 2025;184:221.","journal-title":"Eur J Pediatr"},{"key":"7392_CR4","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41579-022-00713-0","volume":"20","author":"MM Lamers","year":"2022","unstructured":"Lamers MM, Haagmans BL. SARS-CoV-2 pathogenesis. Nat Rev Microbiol. 2022;20:270\u201384.","journal-title":"Nat Rev Microbiol"},{"key":"7392_CR5","doi-asserted-by":"publisher","first-page":"1116131","DOI":"10.3389\/fimmu.2023.1116131","volume":"14","author":"Y Zhu","year":"2023","unstructured":"Zhu Y, Sharma L, Chang D. Pathophysiology and clinical management of coronavirus disease (COVID-19): a mini-review. Front Immunol. 2023;14:1116131.","journal-title":"Front Immunol"},{"key":"7392_CR6","doi-asserted-by":"publisher","first-page":"e072935","DOI":"10.1136\/bmjopen-2023-072935","volume":"13","author":"H Virrantaus","year":"2023","unstructured":"Virrantaus H, Liira H, Posharina T, et al. Prognosis of patients with long COVID symptoms: a protocol for a longitudinal cohort study. BMJ Open. 2023;13:e072935.","journal-title":"BMJ Open"},{"key":"7392_CR7","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1111\/jth.14975","volume":"18","author":"T Iba","year":"2020","unstructured":"Iba T, Levy JH, Levi M, Thachil J. Coagulopathy in COVID-19. J Thromb Haemost. 2020;18:2103\u20139.","journal-title":"J Thromb Haemost"},{"key":"7392_CR8","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s40256-020-00431-z","volume":"20","author":"N Singhania","year":"2020","unstructured":"Singhania N, Bansal S, Nimmatoori DP, et al. Current overview on hypercoagulability in COVID-19. Am J Cardiovasc Drugs. 2020;20:393\u2013403.","journal-title":"Am J Cardiovasc Drugs"},{"key":"7392_CR9","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1177\/02683555211052170","volume":"37","author":"NM Cheng","year":"2022","unstructured":"Cheng NM, Chan YC, Cheng SW. COVID-19-related thrombosis: a mini-review. Phlebology. 2022;37:326\u201337.","journal-title":"Phlebology"},{"key":"7392_CR10","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1016\/j.jtha.2023.05.020","volume":"21","author":"R Kumar","year":"2023","unstructured":"Kumar R, Rivkin MJ, Raffini L. Thrombotic complications in children with coronavirus disease 2019 and multisystem inflammatory syndrome of childhood. J Thromb Haemost. 2023;21:2313\u201326.","journal-title":"J Thromb Haemost"},{"key":"7392_CR11","doi-asserted-by":"publisher","first-page":"6051","DOI":"10.1182\/bloodadvances.2020003471","volume":"4","author":"C Diorio","year":"2020","unstructured":"Diorio C, McNerney KO, Lambert M, et al. Evidence of thrombotic microangiopathy in children with SARS-CoV-2 across the spectrum of clinical presentations. Blood Adv. 2020;4:6051\u201363.","journal-title":"Blood Adv"},{"key":"7392_CR12","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1182\/blood.2020007008","volume":"136","author":"EA Middleton","year":"2020","unstructured":"Middleton EA, He XY, Denorme F, et al. Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome. Blood. 2020;136:1169\u201379.","journal-title":"Blood"},{"key":"7392_CR13","doi-asserted-by":"publisher","first-page":"e30079","DOI":"10.1002\/pbc.30079","volume":"70","author":"A Zabeida","year":"2023","unstructured":"Zabeida A, Winikoff R, Pelland-Marcotte MC, et al. COVID-19-associated coagulopathy in children: a multicenter observational cohort study. Pediatr Blood Cancer. 2023;70:e30079.","journal-title":"Pediatr Blood Cancer"},{"key":"7392_CR14","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.thromres.2021.07.011","volume":"205","author":"M Zaffanello","year":"2021","unstructured":"Zaffanello M, Piacentini G, Nosetti L, et al. Thrombotic risk in children with COVID-19 infection: a systematic review of the literature. Thromb Res. 2021;205:92\u20138.","journal-title":"Thromb Res"},{"key":"7392_CR15","doi-asserted-by":"publisher","first-page":"358","DOI":"10.3390\/hematolrep15020037","volume":"15","author":"MS Rahi","year":"2023","unstructured":"Rahi MS, Parekh J, Pednekar P, et al. Role of therapeutic anticoagulation in COVID-19: the current situation. Hematol Rep. 2023;15:358\u201369.","journal-title":"Hematol Rep"},{"key":"7392_CR16","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1001\/jamainternmed.2023.0625","volume":"183","author":"RC Becker","year":"2023","unstructured":"Becker RC, Ortel TL. Anticoagulation in patients with COVID-19 pneumonia\u2014what is the optimal intensity? JAMA Intern Med. 2023;183:532\u20133.","journal-title":"JAMA Intern Med"},{"key":"7392_CR17","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1111\/cts.13569","volume":"16","author":"Z Mohseni Afshar","year":"2023","unstructured":"Mohseni Afshar Z, Tavakoli Pirzaman A, Hosseinzadeh R, et al. Anticoagulant therapy in COVID-19: a narrative review. Clin Transl Sci. 2023;16:1510\u201325.","journal-title":"Clin Transl Sci"},{"key":"7392_CR18","doi-asserted-by":"publisher","first-page":"e594","DOI":"10.1016\/S2352-3026(22)00173-9","volume":"9","author":"F Cools","year":"2022","unstructured":"Cools F, Virdone S, Sawhney J, et al. Thromboprophylactic low-molecular-weight heparin versus standard of care in unvaccinated, at-risk outpatients with COVID-19 (ETHIC). Lancet Haematol. 2022;9:e594\u2013604.","journal-title":"Lancet Haematol"},{"key":"7392_CR19","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1056\/NEJMoa2103417","volume":"385","author":"EC Goligher","year":"2021","unstructured":"Goligher EC, Bradbury CA, McVerry BJ, et al. Therapeutic anticoagulation with heparin in critically ill patients with Covid-19. N Engl J Med. 2021;385:777\u201389.","journal-title":"N Engl J Med"},{"key":"7392_CR20","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1056\/NEJMoa2105911","volume":"385","author":"PR Lawler","year":"2021","unstructured":"Lawler PR, Goligher EC, Berger JS, et al. Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19. N Engl J Med. 2021;385:790\u2013802.","journal-title":"N Engl J Med"},{"key":"7392_CR21","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1001\/jama.2021.17272","volume":"326","author":"JM Connors","year":"2021","unstructured":"Connors JM, Brooks MM, Sciurba FC, et al. Effect of antithrombotic therapy on clinical outcomes in outpatients with clinically stable symptomatic COVID-19: the ACTIV-4B randomized clinical trial. JAMA. 2021;326:1703\u201312.","journal-title":"JAMA"},{"key":"7392_CR22","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1111\/jth.15073","volume":"18","author":"NA Goldenberg","year":"2020","unstructured":"Goldenberg NA, Sochet A, Albisetti M, et al. Consensus-based clinical recommendations and research priorities for anticoagulant thromboprophylaxis in children hospitalized for COVID-19-related illness. J Thromb Haemost. 2020;18:3099\u2013105.","journal-title":"J Thromb Haemost"},{"key":"7392_CR23","doi-asserted-by":"publisher","first-page":"2275912","DOI":"10.1080\/16078454.2023.2275912","volume":"28","author":"D Xie","year":"2023","unstructured":"Xie D, Xue X, Qiao W, et al. Thrombotic events and prophylactic anticoagulation in pediatric patients with COVID-19: a systematic review and meta-analysis. Hematology. 2023;28:2275912.","journal-title":"Hematology"},{"key":"7392_CR24","doi-asserted-by":"publisher","first-page":"109169","DOI":"10.1016\/j.thromres.2024.109169","volume":"243","author":"S McElroy","year":"2024","unstructured":"McElroy S, Cramer E, Amos L. COVID-19 venous thromboembolism prophylaxis guidelines in pediatrics. Thromb Res. 2024;243:109169.","journal-title":"Thromb Res"},{"key":"7392_CR25","doi-asserted-by":"publisher","first-page":"e12780","DOI":"10.1002\/rth2.12780","volume":"6","author":"AH Schmitz","year":"2022","unstructured":"Schmitz AH, Wood KE, Burghardt EL, et al. Thromboprophylaxis for children hospitalized with COVID-19 and MIS-C. Res Pract Thromb Haemost. 2022;6:e12780.","journal-title":"Res Pract Thromb Haemost"},{"key":"7392_CR26","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s40272-023-00566-x","volume":"25","author":"H Sahrai","year":"2023","unstructured":"Sahrai H, Hemmati-Ghavshough M, Shahrabi M, et al. Thromboprophylaxis for coagulopathy related to COVID-19 in pediatrics: a narrative review. Paediatr Drugs. 2023;25:443\u201352.","journal-title":"Paediatr Drugs"},{"issue":"6","key":"7392_CR27","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.3390\/jcm12062222","volume":"12","author":"S Rachina","year":"2023","unstructured":"Rachina S, Belkova Y, Shchendrygina A, et al. Safety and efficacy of different anticoagulant doses for patients with COVID-19 in the ICU: a systematic review and meta-analysis. J Clin Med. 2023;12(6):2222.","journal-title":"J Clin Med"},{"key":"7392_CR28","doi-asserted-by":"publisher","first-page":"162","DOI":"10.14740\/jh836","volume":"10","author":"G Kumar","year":"2021","unstructured":"Kumar G, Patel D, Odeh T, et al. Incidence of venous thromboembolism and effect of anticoagulant dosing in hospitalized COVID-19 patients. J Hematol. 2021;10:162\u201370.","journal-title":"J Hematol"},{"key":"7392_CR29","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1182\/blood.2021014527","volume":"140","author":"L Baumann Kreuziger","year":"2022","unstructured":"Baumann Kreuziger L, Sholzberg M, Cushman M. Anticoagulation in hospitalized patients with COVID-19. Blood. 2022;140:809\u201314.","journal-title":"Blood"},{"key":"7392_CR30","doi-asserted-by":"publisher","first-page":"59","DOI":"10.7326\/ANNALS-24-00800","volume":"178","author":"CL Vale","year":"2025","unstructured":"Vale CL, Godolphin PJ, Fisher DJ, et al. Anticoagulation among patients hospitalized for COVID-19: a systematic review and prospective meta-analysis. Ann Intern Med. 2025;178:59\u201369.","journal-title":"Ann Intern Med"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-026-07392-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-026-07392-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-026-07392-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:02:57Z","timestamp":1792587777000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-026-07392-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7392"],"URL":"https:\/\/doi.org\/10.1186\/s12887-026-07392-3","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"assertion":[{"value":"18 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of Children\u2019s Hospital 1, Ho Chi Minh City, Vietnam (approval code: CS\/N1\/21\/65). Informed consent was waived due to the study\u2019s retrospective design, in accordance with the Ethics Committee\u2019s policies.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1035"}}